FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4292059779> ?p ?o ?g. }

• W4292059779 abstract "Rapid diagnosis is a cornerstone for controlling and preventing viral disease outbreaks. The present study is aimed to develop a rapid field diagnostic test based on gold nanoparticles for the detection of lumpy skin diseases (LSD), and foot and mouth diseases (FMD) in animals with high sensitivity and specificity.FMD and LSD vaccines were used as a source of viruses' antigens for preparing monoclonal antibodies and conjugated with gold nanoparticles that characterized using various techniques such as UV-visible spectrometry, and transmission electron microscopy (TEM). Monoclonal antibodies (mAbs) for each serotype produced in experimental rats and used to capture antibodies for FMDV and/or LSDV. ELISA was used to screen 469 milk samples and 1165 serum samples from naturally infected cattle, buffaloes, sheep, and goats for validation of the lateral flow test (LFT). LSDV DNA was extracted from 117 blood and skin biopsy samples collected from naturally infected cattle during the 2019 outbreak.The specificity and sensitivity of GNP-LFT were evaluated and compared to Ag-ELISA, Western blot tests (WB), and PCR. A total of 95 FMDV positives out of 469 (20.25%) milk samples and 268 FMDV positives out of 1165 (23.3%) serum samples from natural infected cattle, buffaloes, sheep, and goats examined by ELISA to valid GNPS-LFT Viral LSDV DNA was detected in 60/117 (51.5%) and 31/60 (52.9%). While the GNPS-LFT assay results were 49/117 (41.9%) and 29/60 (48.3%) blood and skin biopsy samples, respectively. The diagnostic sensitivity and specificity of the GNP-LFT test were 72% and 82%, respectively. All vesicular fluid and epithelium samples collected from infected animals were identified as positive by the GNP-LFT and Ag-ELISA. Ag-ELISA, on the other hand, was 90% and 100%. While the developed GNP-LFT used LSDV polyclonal antibodies were similar to ELISA and IgG-WB with a sensitivity of 72.8% and a specificity of 88.8%, respectively.The GNPS-LFT is a novel immunoassay based on mono or polyclonal antibodies conjugated with gold nanoparticles that provides an accurate, rapid, specific, and sensitive tool for field rapid diagnosis of FMDV and LSDV." @default.
• W4292059779 created "2022-08-17" @default.
• W4292059779 creator A5020654676 @default.
• W4292059779 creator A5024172194 @default.
• W4292059779 creator A5078718011 @default.
• W4292059779 creator A5087010059 @default.
• W4292059779 date "2022-08-14" @default.
• W4292059779 modified "2023-09-30" @default.
• W4292059779 title "Development of gold nanoparticles-lateral flow test as a novel field diagnostic assay for detecting foot-and-mouth disease and lumpy skin disease viruses" @default.
• W4292059779 cites W1965774729 @default.
• W4292059779 cites W1992152250 @default.
• W4292059779 cites W2000053681 @default.
• W4292059779 cites W2023536718 @default.
• W4292059779 cites W2041840364 @default.
• W4292059779 cites W2399980125 @default.
• W4292059779 cites W2525253474 @default.
• W4292059779 cites W2599811894 @default.
• W4292059779 cites W2724444177 @default.
• W4292059779 cites W2746723492 @default.
• W4292059779 cites W2773052864 @default.
• W4292059779 cites W2789675206 @default.
• W4292059779 cites W2810540320 @default.
• W4292059779 cites W2883080958 @default.
• W4292059779 cites W2883600975 @default.
• W4292059779 cites W2897259139 @default.
• W4292059779 cites W2921430890 @default.
• W4292059779 cites W2930823865 @default.
• W4292059779 cites W2935858236 @default.
• W4292059779 cites W2945151361 @default.
• W4292059779 cites W2945158804 @default.
• W4292059779 cites W2962855775 @default.
• W4292059779 cites W2972757728 @default.
• W4292059779 cites W2981637045 @default.
• W4292059779 cites W2981824478 @default.
• W4292059779 cites W2993744977 @default.
• W4292059779 cites W3110269112 @default.
• W4292059779 cites W3122367927 @default.
• W4292059779 cites W3126899376 @default.
• W4292059779 cites W3136369812 @default.
• W4292059779 cites W3158874152 @default.
• W4292059779 cites W3176681936 @default.
• W4292059779 cites W3200483987 @default.
• W4292059779 cites W4205444139 @default.
• W4292059779 cites W4206995195 @default.
• W4292059779 cites W4220923392 @default.
• W4292059779 cites W4224847269 @default.
• W4292059779 cites W4281392464 @default.
• W4292059779 cites W4282923288 @default.
• W4292059779 doi "https://doi.org/10.18502/ijm.v14i4.10245" @default.
• W4292059779 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36721504" @default.
• W4292059779 hasPublicationYear "2022" @default.
• W4292059779 type Work @default.
• W4292059779 citedByCount "1" @default.
• W4292059779 countsByYear W42920597792023 @default.
• W4292059779 crossrefType "journal-article" @default.
• W4292059779 hasAuthorship W4292059779A5020654676 @default.
• W4292059779 hasAuthorship W4292059779A5024172194 @default.
• W4292059779 hasAuthorship W4292059779A5078718011 @default.
• W4292059779 hasAuthorship W4292059779A5087010059 @default.
• W4292059779 hasBestOaLocation W42920597791 @default.
• W4292059779 hasConcept C104819515 @default.
• W4292059779 hasConcept C116675565 @default.
• W4292059779 hasConcept C126322002 @default.
• W4292059779 hasConcept C130840561 @default.
• W4292059779 hasConcept C155672457 @default.
• W4292059779 hasConcept C159047783 @default.
• W4292059779 hasConcept C159654299 @default.
• W4292059779 hasConcept C171250308 @default.
• W4292059779 hasConcept C192562407 @default.
• W4292059779 hasConcept C203014093 @default.
• W4292059779 hasConcept C2522874641 @default.
• W4292059779 hasConcept C2776151397 @default.
• W4292059779 hasConcept C2779070877 @default.
• W4292059779 hasConcept C40993552 @default.
• W4292059779 hasConcept C542903549 @default.
• W4292059779 hasConcept C54355233 @default.
• W4292059779 hasConcept C552990157 @default.
• W4292059779 hasConcept C71924100 @default.
• W4292059779 hasConcept C86803240 @default.
• W4292059779 hasConceptScore W4292059779C104819515 @default.
• W4292059779 hasConceptScore W4292059779C116675565 @default.
• W4292059779 hasConceptScore W4292059779C126322002 @default.
• W4292059779 hasConceptScore W4292059779C130840561 @default.
• W4292059779 hasConceptScore W4292059779C155672457 @default.
• W4292059779 hasConceptScore W4292059779C159047783 @default.
• W4292059779 hasConceptScore W4292059779C159654299 @default.
• W4292059779 hasConceptScore W4292059779C171250308 @default.
• W4292059779 hasConceptScore W4292059779C192562407 @default.
• W4292059779 hasConceptScore W4292059779C203014093 @default.
• W4292059779 hasConceptScore W4292059779C2522874641 @default.
• W4292059779 hasConceptScore W4292059779C2776151397 @default.
• W4292059779 hasConceptScore W4292059779C2779070877 @default.
• W4292059779 hasConceptScore W4292059779C40993552 @default.
• W4292059779 hasConceptScore W4292059779C542903549 @default.
• W4292059779 hasConceptScore W4292059779C54355233 @default.
• W4292059779 hasConceptScore W4292059779C552990157 @default.
• W4292059779 hasConceptScore W4292059779C71924100 @default.
• W4292059779 hasConceptScore W4292059779C86803240 @default.
• W4292059779 hasLocation W42920597791 @default.
• W4292059779 hasLocation W42920597792 @default.

• next